Back to newsCalifornia Resources Corporation <CRC.N>: Barclays cuts target price to $77 from $80CCRC•2026-08-11Related NewsCC4 Therapeutics Q2 revenue beats estimates, helped by Roche collaborationCCCC•2026-08-11RRapid7, Inc. <RPD.O>: Stifel raises target price to $13 from $7RPD•2026-08-11MMiddleby Q2 sales rise; lifts forecastMIDD•2026-08-11CCalciMedica Q2 net loss widensCALC•2026-08-11M908 Devices Q2 revenue beats on increased VipIR salesMASS•2026-08-11
CRC•
